Amalgamated Bank’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
12,536
-780
-6% -$18.3K ﹤0.01% 1488
2026
Q1
$187K Sell
13,316
-373
-3% -$5.03K ﹤0.01% 1573
2025
Q4
$154K Buy
13,689
+76
+0.6% +$870 ﹤0.01% 1624
2025
Q3
$157K Buy
13,613
+493
+4% +$5.77K ﹤0.01% 1626
2025
Q2
$161K Hold
13,120
﹤0.01% 1602
2025
Q1
$188K Sell
13,120
-364
-3% -$5.68K ﹤0.01% 1550
2024
Q4
$215K Sell
13,484
-122
-0.9% -$2.41K ﹤0.01% 1558
2024
Q3
$327K Sell
13,606
-392
-3% -$8.96K ﹤0.01% 1450
2024
Q2
$279K Sell
13,998
-54
-0.4% -$1.05K ﹤0.01% 1490
2024
Q1
$280K Sell
14,052
-3,640
-21% -$70.4K ﹤0.01% 1504
2023
Q4
$397K Sell
17,692
-472
-3% -$9.74K ﹤0.01% 1530
2023
Q3
$367K Sell
18,164
-545
-3% -$12.4K ﹤0.01% 1553
2023
Q2
$478K Sell
18,709
-789
-4% -$20.8K ﹤0.01% 1457
2023
Q1
$580K Sell
19,498
-1,604
-8% -$46.6K ﹤0.01% 1359
2022
Q4
$571K Hold
21,102
0.01% 1406
2022
Q3
$460K Sell
21,102
-185
-0.9% -$4.83K ﹤0.01% 1474
2022
Q2
$582K Sell
21,287
-357
-2% -$10.3K 0.01% 1395
2022
Q1
$725K Sell
21,644
-1,069
-5% -$34.4K 0.01% 1372
2021
Q4
$787K Sell
22,713
-197
-0.9% -$6.37K 0.01% 1350
2021
Q3
$715K Sell
22,910
-465
-2% -$15.8K 0.01% 1413
2021
Q2
$850K Buy
+23,375
New +$967K 0.01% 1363
2021
Q1
Sell
-4,535
Closed -$208K 1603
2020
Q4
$208K Buy
+4,535
New +$189K 0.01% 1430
2020
Q2
Sell
-7,716
Closed -$208K 1499
2020
Q1
$208K Sell
7,716
-219
-3% -$6.54K 0.01% 1346
2019
Q4
$267K Buy
7,935
+673
+9% +$24.4K ﹤0.01% 1481
2019
Q3
$272K Sell
7,262
-176
-2% -$6.71K 0.01% 1370
2019
Q2
$324K Buy
7,438
+539
+8% +$23.1K 0.01% 1313
2019
Q1
$294K Buy
6,899
+230
+3% +$10.3K 0.01% 1276
2018
Q4
$299K Sell
6,669
-127
-2% -$6.65K 0.01% 1175
2018
Q3
$466K Sell
6,796
-78
-1% -$5.02K 0.01% 968
2018
Q2
$394K Buy
6,874
+227
+3% +$12K 0.01% 1157
2018
Q1
$306K Sell
6,647
-82
-1% -$3.89K 0.01% 1201
2017
Q4
$311K Buy
6,729
+444
+7% +$20.4K 0.01% 1247
2017
Q3
$283K Sell
6,285
-370
-6% -$15.8K 0.01% 1243
2017
Q2
$261K Buy
6,655
+82
+1% +$3.1K 0.01% 1277
2017
Q1
$250K Buy
6,573
+7
+0.1% +$273 0.01% 1255
2016
Q4
$243K Buy
6,566
+749
+13% +$26.8K 0.01% 1273
2016
Q3
$202K Buy
5,817
+8
+0.1% +$280 0.01% 1264
2016
Q2
$211K Buy
+5,809
New +$178K 0.01% 1223
2015
Q3
Sell
-5,014
Closed -$203K 1316
2015
Q2
$203K Buy
+5,014
New +$225K 0.02% 1242

Other funds holding AVNS

Amalgamated Bank's AVNS Position: Q2 2026 in Review

Amalgamated Bank reduced its Avanos Medical (AVNS) stake by 5.9% in Q2 2026, selling an estimated $18.3K and leaving 12,536 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

Amalgamated Bank first reported a position in AVNS in Q2 2015 and has held it in 39 quarters since. The position peaked at $850K in Q2 2021. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Amalgamated Bank held 12,536 shares of Avanos Medical worth $312K as of Q2 2026.
  • Amalgamated Bank sold 780 Avanos Medical shares in Q2 2026, an estimated $18.3K.
  • Avanos Medical made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1488 holding.
  • Amalgamated Bank first reported a position in Avanos Medical in Q2 2015 and has held it in 39 quarters since.
  • Amalgamated Bank's Avanos Medical position peaked at $850K in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.